Streetbeat News

Equity Actions

BFRG

Bullfrog AI's stock is trading lower following the announcement of a $5.7 million public offering, which includes 1,507,139 shares priced at $3.782 each.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 5:35 pm

REVB

Revelation Biosciences shares are trading lower following the announcement of a $6.2 million offering.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 5:29 pm

MU

Investors have shown a bearish stance on Micron Technology (NASDAQ:MU), with options trading data revealing a split sentiment of 22% bullish and 77% bearish. The options trades indicate a price target window of $70.0 to $92.5 for MU. The trading volume and open interest suggest significant activity in MU options, with a notable shift towards bearish positions. Micron Technology, a major semiconductor company, is currently trading at $86.06, with an upcoming earnings announcement in 54 days.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 5:00 pm

KPRX

Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) shares surged after announcing a private placement of up to $45 million and an exclusive license and development agreement with Théa Open Innovation SAS. The deal includes an upfront payment of $16 million to Kiora, potential milestone payments of up to $285 million, and tiered royalties on net sales. Additionally, Kiora will issue 15,800,000 shares and warrants to institutional investors for approximately $15 million, with potential future proceeds of $30 million from warrant exercises. KPRX's stock is currently trading above its 200-day moving average, indicating a bullish signal.

Portfolio Pulse from Erica Kollmann

February 01, 2024 | 4:57 pm

SHEL

Shell's shares surged following the announcement of better-than-expected Q4 financial results, FY24 guidance, a $3.5 billion share buyback program, and a 4% dividend increase for Q4.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 4:57 pm

KPRX

Kiora Pharmaceuticals' stock is trading higher following the announcement of a private placement worth up to approximately $45 million.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 4:56 pm

CTVA

Corteva, Inc. (NYSE:CTVA) shares rose after reporting Q4 financial results surpassing analyst estimates and announcing a $1 billion repurchase plan. Adjusted earnings were 15 cents per share, a slight decrease from the previous year, with sales also seeing a minor decline. The repurchase plan is set for 2024. Mizuho analyst Chris Parkinson maintained a Buy rating but lowered the price target from $59 to $56. Corteva's stock is trading above its 50-day moving average but below its 52-week high.

Portfolio Pulse from Erica Kollmann

February 01, 2024 | 4:51 pm

ADI

An analysis of Analog Devices (ADI) and its competitors in the Semiconductors & Semiconductor Equipment industry reveals ADI's potential for growth despite its lower ROE, EBITDA, and revenue growth compared to industry averages. The company's lower P/E, P/B, and P/S ratios suggest potential undervaluation. ADI's stronger financial position is highlighted by its favorable debt-to-equity ratio compared to top peers.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 4:00 pm

ADBE

A comparative study evaluates Adobe (NASDAQ:ADBE) against its competitors in the Software industry, analyzing financial metrics, market position, and growth prospects. Adobe's P/E ratio is below the industry average, suggesting growth potential, while its P/B ratio indicates potential undervaluation. However, its high P/S ratio may suggest overvaluation in sales performance. Adobe's ROE is below the industry average, indicating potential inefficiency, but its EBITDA and gross profit are significantly above the industry average, demonstrating strong profitability. The company's revenue growth is slightly lower than the industry average, and it has a lower debt-to-equity ratio compared to its top 4 peers, indicating a stronger financial position. The analysis presents a mixed outlook for Adobe in the software industry.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 4:00 pm

EQR

Equity Residential (NYSE:EQR) has received mixed ratings from analysts, with a shift towards a more neutral stance in the last 30 days. The average 12-month price target has been adjusted to $60.5, down from $63.20, reflecting a 4.27% decrease. Analysts from RBC Capital, Mizuho, Stifel, and Piper Sandler have updated their ratings and price targets, indicating varied expectations for EQR's performance. Equity Residential, with a portfolio of 304 apartment communities, shows solid financial indicators such as a net margin of 42.74% and ROE of 2.82%, despite a lower revenue growth rate compared to the industry average.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 4:00 pm